Sort
261,768 grants matching “gene therapy”
Cellular Interactions with Thrombospondin
$880,854David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Innate, Transcriptomic, and Microbiomic correlates of TB infection
$880,842Michael Haggai Glickman · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma
$880,830Nicole Schmitt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2017 · DC
Biology and Therapy of Lymphopenia
$880,808Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
In vivo hematopoietic stem cell engineering for HIV cure
$880,758Hans-Peter Kiem · University Of Southern California · P01 · FY2025 · HL
Clinical, genetic and cardiometabolic risk correlates of the gut microbiome
$880,725Stanley Y Shaw · Broad Institute, Inc. · R01 · FY2019 · HL
Targeting PD-1 Pathway for Functional Cure of AIDS
$880,613Rama Rao Amara · Emory University · R01 · FY2025 · AI
Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens
$880,606Daniel E Kahne · Harvard Medical School · U19 · FY2017 · AI
Growth Factor Imaging
$880,575Peter L. Choyke · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer
$880,570Jixin Dong · University Of Nebraska Medical Center · R01 · FY2025 · CA
Modeling Type II Diabetes and Lipodystrophy Using Patient-Specific iPS Cells
$880,560Haiming Cao · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Determining the Fate of Transmembrane Proteins
$880,528Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Novel DNA Repair Inhibitors for Cancer Therapy
$880,502Peter M Glazer · Yale University · R35 · FY2019 · CA
QC and Release Testing of Vector and Cell Clinical Gene Therapy Products
$880,425Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Clinical Development of Novel Drugs for Children with Refractory Cancers
$880,382Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
programmed cell death in regulation of autoimmunity
$880,278Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2009 · AR
Identifying de novo mutations causing OCD in trios by whole exome sequencing
$880,214David B. Goldstein · Columbia University Health Sciences · R01 · FY2017 · MH
Strategies for Prevention of Autoimmunity
$880,068Stanford University · U19 · FY2002 · DK
Thyroid Hormone Nuclear Receptors in Health and Disease
$880,039Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Preclinical Mouse Models of Thyroid Cancer
$880,039Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
$880,013David W Crabb · Indiana University Indianapolis · U01 · FY2013 · AA
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors
$880,000Michael Emerman · Fred Hutchinson Cancer Center · DP1 · FY2023 · DA
Role of the SERRATE protein in regulation of miRNA biogenesis and transposable element silencing in Arabidopsis thaliana
$880,000Xiuren Zhang · Texas A&M Agrilife Research · · FY2017 · BIO
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors
$880,000Michael Emerman · Fred Hutchinson Cancer Center · DP1 · FY2022 · DA
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors
$880,000Michael Emerman · Fred Hutchinson Cancer Research Center · DP1 · FY2021 · DA